These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31571947)

  • 1. Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review.
    Azimi T; Mosadegh M; Nasiri MJ; Sabour S; Karimaei S; Nasser A
    Infect Drug Resist; 2019; 12():2943-2959. PubMed ID: 31571947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the molecular properties and anti-mycobacterial activity of cysteine peptidase domain of D29 mycobacteriophage endolysin.
    Gangakhedkar R; Jain V
    J Virol; 2024 Oct; 98(10):e0132824. PubMed ID: 39287392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections.
    Ouyang X; Li X; Song J; Wang H; Wang S; Fang R; Li Z; Song N
    Front Microbiol; 2023; 14():1277178. PubMed ID: 37840750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review.
    Zeynali Kelishomi F; Khanjani S; Fardsanei F; Saghi Sarabi H; Nikkhahi F; Dehghani B
    BMC Infect Dis; 2022 Dec; 22(1):957. PubMed ID: 36550444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Bacteriophages for Mycobacterial Infections, from Diagnosis to Treatment.
    Shield CG; Swift BMC; McHugh TD; Dedrick RM; Hatfull GF; Satta G
    Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.
    Dedrick RM; Smith BE; Cristinziano M; Freeman KG; Jacobs-Sera D; Belessis Y; Whitney Brown A; Cohen KA; Davidson RM; van Duin D; Gainey A; Garcia CB; Robert George CR; Haidar G; Ip W; Iredell J; Khatami A; Little JS; Malmivaara K; McMullan BJ; Michalik DE; Moscatelli A; Nick JA; Tupayachi Ortiz MG; Polenakovik HM; Robinson PD; Skurnik M; Solomon DA; Soothill J; Spencer H; Wark P; Worth A; Schooley RT; Benson CA; Hatfull GF
    Clin Infect Dis; 2023 Jan; 76(1):103-112. PubMed ID: 35676823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on Mycobacteriophages: From Classification to Applications.
    Hosseiniporgham S; Sechi LA
    Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains.
    Guerrero-Bustamante CA; Dedrick RM; Garlena RA; Russell DA; Hatfull GF
    mBio; 2021 May; 12(3):. PubMed ID: 34016711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycobacterial Potential of Mycobacteriophage Under Disease-Mimicking Conditions.
    Kalapala YC; Sharma PR; Agarwal R
    Front Microbiol; 2020; 11():583661. PubMed ID: 33381088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacteriophages: therapeutic approach for mycobacterial infections.
    Raman SK; Siva Reddy DV; Jain V; Bajpai U; Misra A; Singh AK
    Drug Discov Today; 2024 Jul; 29(7):104049. PubMed ID: 38830505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage in the diagnosis and treatment of tuberculosis.
    Guo S; Ao Z
    Front Biosci (Landmark Ed); 2012 Jun; 17(7):2691-7. PubMed ID: 22652807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting intracellular nontuberculous mycobacteria and
    Bartlett HP; Dawson CC; Glickman CM; Osborn DW; Evans CR; Garcia BJ; Frost LC; Cummings JE; Whittel N; Slayden RA; Holder JW
    Microbiol Spectr; 2024 May; 12(5):e0353423. PubMed ID: 38534149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent Reporter DS6A Mycobacteriophages Reveal Unique Variations in Infectibility and Phage Production in Mycobacteria.
    Mayer O; Jain P; Weisbrod TR; Biro D; Ho L; Jacobs-Sera D; Hatfull GF; Jacobs WR
    J Bacteriol; 2016 Dec; 198(23):3220-3232. PubMed ID: 27672191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside Antibiotics Inhibit Mycobacteriophage Infection.
    Jiang Z; Wei J; Liang Y; Peng N; Li Y
    Antibiotics (Basel); 2020 Oct; 9(10):. PubMed ID: 33086520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.
    Taati Moghadam M; Amirmozafari N; Shariati A; Hallajzadeh M; Mirkalantari S; Khoshbayan A; Masjedian Jazi F
    Infect Drug Resist; 2020; 13():45-61. PubMed ID: 32021319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phages for the treatment of Mycobacterium species.
    Opperman CJ; Wojno J; Goosen W; Warren R
    Prog Mol Biol Transl Sci; 2023; 201():41-92. PubMed ID: 37770176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.